ArticleCancer management and research2024

Feasibility and Tolerability of Anlotinib Plus PD-1 Blockades for Patients with Treatment-Refractory Metastatic Colorectal Cancer: A Retrospective Exploratory Study.

Hua Bai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.